TXG logo

10x Genomics, Inc. (TXG) Free Cash Flow

Annual FCF:

-$6.73M+$57.99M(+89.60%)
December 31, 2024

Summary

  • As of today, TXG annual free cash flow is -$6.73 million, with the most recent change of +$57.99 million (+89.60%) on December 31, 2024.
  • During the last 3 years, TXG annual free cash flow has risen by +$115.92 million (+94.51%).
  • TXG annual free cash flow is now at all-time high.

Performance

TXG Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Quarterly FCF:

$33.91M+$17.78M(+110.24%)
September 30, 2025

Summary

  • As of today, TXG quarterly free cash flow is $33.91 million, with the most recent change of +$17.78 million (+110.24%) on September 30, 2025.
  • Over the past year, TXG quarterly free cash flow has increased by +$16.16 million (+91.03%).
  • TXG quarterly free cash flow is now at all-time high.

Performance

TXG Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM FCF:

$73.03M+$16.16M(+28.41%)
September 30, 2025

Summary

  • As of today, TXG TTM free cash flow is $73.03 million, with the most recent change of +$16.16 million (+28.41%) on September 30, 2025.
  • Over the past year, TXG TTM free cash flow has increased by +$47.99 million (+191.64%).
  • TXG TTM free cash flow is now at all-time high.

Performance

TXG TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TXG Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+89.6%+91.0%+191.6%
3Y3 Years+94.5%+173.5%+145.3%
5Y5 Years+17.3%+159.6%+170.4%

TXG Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+95.9%at high+173.5%at high+144.2%
5Y5-Yearat high+97.4%at high+122.3%at high+125.3%
All-TimeAll-Timeat high+97.4%at high+122.3%at high+125.3%

TXG Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$33.91M(+110.2%)
$73.03M(+28.4%)
Jun 2025
-
$16.13M(-50.3%)
$56.88M(+28.2%)
Mar 2025
-
$32.46M(+443.0%)
$44.36M(+759.3%)
Dec 2024
-$6.73M(+89.6%)
-$9.46M(-153.3%)
-$6.73M(-126.9%)
Sep 2024
-
$17.75M(+390.7%)
$25.04M(+174.9%)
Jun 2024
-
$3.62M(+119.4%)
-$33.45M(+54.8%)
Mar 2024
-
-$18.64M(-183.5%)
-$73.95M(-14.3%)
Dec 2023
-$64.72M(+60.8%)
$22.31M(+154.8%)
-$64.72M(+42.7%)
Sep 2023
-
-$40.74M(-10.5%)
-$113.04M(+4.6%)
Jun 2023
-
-$36.88M(-292.1%)
-$118.44M(+5.8%)
Mar 2023
-
-$9.41M(+63.8%)
-$125.74M(+23.9%)
Dec 2022
-$165.27M
-$26.01M(+43.6%)
-$165.27M(-2.6%)
Sep 2022
-
-$46.14M(-4.4%)
-$161.07M(+0.2%)
Jun 2022
-
-$44.18M(+9.7%)
-$161.38M(-25.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$48.94M(-124.4%)
-$128.64M(-4.9%)
Dec 2021
-$122.65M(+52.1%)
-$21.81M(+53.0%)
-$122.65M(+51.6%)
Sep 2021
-
-$46.44M(-305.7%)
-$253.28M(+4.0%)
Jun 2021
-
-$11.45M(+73.3%)
-$263.77M(+8.6%)
Mar 2021
-
-$42.95M(+71.8%)
-$288.58M(-12.6%)
Dec 2020
-$256.29M(-3048.6%)
-$152.44M(-167.7%)
-$256.29M(-147.1%)
Sep 2020
-
-$56.94M(-57.0%)
-$103.73M(-125.8%)
Jun 2020
-
-$36.26M(-240.3%)
-$45.95M(-145.1%)
Mar 2020
-
-$10.65M(-9053.8%)
-$18.75M(-130.3%)
Dec 2019
-$8.14M(+90.2%)
$119.00K(-86.0%)
-$8.14M(+1.4%)
Sep 2019
-
$848.00K(+109.4%)
-$8.26M(+9.3%)
Jun 2019
-
-$9.06M(>-9900.0%)
-$9.11M(>-9900.0%)
Mar 2019
-
-$49.00K
-$49.00K
Dec 2018
-$83.12M(-475.0%)
-
-
Dec 2017
-$14.46M
-
-

FAQ

  • What is 10x Genomics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual free cash flow year-on-year change?
  • What is 10x Genomics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly free cash flow year-on-year change?
  • What is 10x Genomics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM free cash flow year-on-year change?

What is 10x Genomics, Inc. annual free cash flow?

The current annual free cash flow of TXG is -$6.73M

What is the all-time high annual free cash flow for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual free cash flow is -$6.73M

What is 10x Genomics, Inc. annual free cash flow year-on-year change?

Over the past year, TXG annual free cash flow has changed by +$57.99M (+89.60%)

What is 10x Genomics, Inc. quarterly free cash flow?

The current quarterly free cash flow of TXG is $33.91M

What is the all-time high quarterly free cash flow for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly free cash flow is $33.91M

What is 10x Genomics, Inc. quarterly free cash flow year-on-year change?

Over the past year, TXG quarterly free cash flow has changed by +$16.16M (+91.03%)

What is 10x Genomics, Inc. TTM free cash flow?

The current TTM free cash flow of TXG is $73.03M

What is the all-time high TTM free cash flow for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM free cash flow is $73.03M

What is 10x Genomics, Inc. TTM free cash flow year-on-year change?

Over the past year, TXG TTM free cash flow has changed by +$47.99M (+191.64%)
On this page